TuHURA Biosciences Valuation
| HURA Stock | 4.48 0.48 12.00% |
At this time, the company appears to be undervalued. TuHURA Biosciences has a current Real Value of USD7.03 per share. The regular price of the company is USD4.48. Our model measures the value of TuHURA Biosciences from inspecting the company fundamentals such as current valuation of 193.58 M, and Net Income of (29.32 M) as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting TuHURA Biosciences' valuation include:
Price Book 133.7815 | Enterprise Value 193.6 M |
Undervalued
Today
Please note that TuHURA Biosciences' price fluctuation is very risky at this time. Calculation of the real value of TuHURA Biosciences is based on 3 months time horizon. Increasing TuHURA Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since TuHURA Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of TuHURA Stock. However, TuHURA Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.48 | Real 7.03 | Target 15.0 | Hype 4.31 | Naive 2.72 |
The real value of TuHURA Stock, also known as its intrinsic value, is the underlying worth of TuHURA Biosciences Company, which is reflected in its stock price. It is based on TuHURA Biosciences' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of TuHURA Biosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of TuHURA Biosciences helps investors to forecast how TuHURA stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of TuHURA Biosciences more accurately as focusing exclusively on TuHURA Biosciences' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use TuHURA Biosciences' intrinsic value based on its ongoing forecasts of TuHURA Biosciences' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against TuHURA Biosciences' closest peers. If more than one evaluation category is relevant for TuHURA Biosciences we suggest using both methods to arrive at a better estimate.
TuHURA Biosciences Cash |
|
TuHURA Valuation Trend
Comparing TuHURA Biosciences' enterprise value against its market capitalization is a good way to estimate the value of TuHURA Biosciences uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
TuHURA Biosciences Total Value Analysis
TuHURA Biosciences is currently projected to have valuation of 193.58 M with market capitalization of 141.65 M, debt of 2.34 M, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the TuHURA Biosciences fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
193.58 M | 141.65 M | 2.34 M |
TuHURA Biosciences Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of TuHURA suggests not a very effective usage of assets in December.TuHURA Biosciences Profitability Analysis
Net Loss for the year was (29.32 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates TuHURA Biosciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in TuHURA Biosciences and how it compares across the competition.
About TuHURA Biosciences Valuation
The stock valuation mechanism determines TuHURA Biosciences' current worth on a weekly basis. Our valuation model uses a comparative analysis of TuHURA Biosciences. We calculate exposure to TuHURA Biosciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of TuHURA Biosciences's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -28.8 K | -30.2 K |
TuHURA Biosciences Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 68 M |
TuHURA Biosciences Current Valuation Indicators
Valuation refers to the process of determining the present value of TuHURA Biosciences and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value TuHURA we look at many different elements of the entity such as TuHURA's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as TuHURA Biosciences, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use TuHURA Biosciences' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes TuHURA Biosciences' worth.Complementary Tools for TuHURA Stock analysis
When running TuHURA Biosciences' price analysis, check to measure TuHURA Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TuHURA Biosciences is operating at the current time. Most of TuHURA Biosciences' value examination focuses on studying past and present price action to predict the probability of TuHURA Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TuHURA Biosciences' price. Additionally, you may evaluate how the addition of TuHURA Biosciences to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |